metastatic Colorectal Cancer - Globe Thesis

Keyword [metastatic Colorectal Cancer] Result: 101 - 119 \| Page: 6 of 6
101.	Study On The Relationship Between TCM Syndromes Of Non-metastatic Colorectal Cancer And Metastatic Colorectal Cancer
102.	Professor Yang Yufei's Clinical Application Research On Strengthening The Spleen, Nourishing The Kidney And Detoxification Method In Advanced Colorectal Cancer
103.	Synergistic DNA + Adenovirus Prime-Boost Immunization in Metastatic Colorectal Cancer
104.	Qualitative Transcriptional Signature For Predicting Pathological Response And Prognosis Of Colorectal Cancer To FOLFOXTherapy
105.	Study On The Efficacy And Safety Of Apatinib In The Treatment Of Metastatic Colorectal Cancer And Synergistic Effect Of Combined PD-1 Inhibitor
106.	Analysis Of The Efficacy,Safety And Efficacy Prediction Of Regorafenib In Third-line Treatment Of Metastatic Colorectal Cancer
107.	Effect Observation And Prognosis Analysis Of Regofinib Third-line And Above For The Advanced Metastatic Colorectal Cancer
108.	A Randomized Controlled Trial Of CAPRINOX Or FOLFOXIRI In The Treatment Of Locally Advanced Or Metastatic Colorectal Cancer
109.	Clinical Observation Of Fuzi Lizhong Decoction Combined With Chemotherapy On Patients With Advanced Metastatic Colorectal Cancer Of Spleen Kidney Yang Deficiency Type
110.	Long-term Follow-up Study Of The Efficacy And Safety Of Bevacizumab Combined With Chemotherapy In The Treatment Of Metastatic Colorectal Cancer
111.	Prognostic Value Of C-reactive Protein To Albumin Ratio In Stage ? Colorectal Cancer
112.	Efficacy And Safety Of Maintenance Therapy Contained With Anti-EGFR Monoclonal Antibody In RAS And BRAF Wild-type Metastatic Colorectal Cancer
113.	Analysis Of Clinical Efficacy And Prognosis Of Apatinib Mesylate For Third-line Or Above Third-line Treatment Of Metastatic Colorectal Cancer
114.	Low-dose Apatinib Combined With S-1 In Refractory Metastatic Colorectal Cancer
115.	Retrospective Study Of Fuzheng Anzhong Decoction Combined With Chemotherapy In The Treatment Of Metastatic Colorectal Cancer With Deficiency Of Both Qi And Yin
116.	Mechanism Study Of PIK3CA Promotes Resistance To Regorafenib In Metastatic Colorectal Cancer
117.	Survival Analysis And Prognostic Factors Of Palliative Radiotherapy In Patients With Metastatic Colorectal Cancer
118.	Analysis Of Efficacy And Safety In Treating Advanced Colorectal Cancer With Fruquintinib
119.	Association Between Bevacizumab-related Hypertension And Outcomes Of Metastatic Colorectal Cancer Patients:a Meta Analysis
<<First <Prev Next> Last>> Jump to